Posted inMarket
Eli Lilly-Backed Scribe Therapeutics Surges 67% Following $128.7 Million Upsized IPO
On Thursday, Scribe Therapeutics surged 67% during its market debut on the Nasdaq after raising $128.7 million in an upsized initial public offering, signaling renewed investor enthusiasm for early-stage genetic…
